Galectin-3 expression in functioning and silent ACTH-producing adenomas

Endocrine Pathology

Volumn 16, Issue 2, 2005, Pages 107-114

  Jin, Long ^a   Riss, Dominik ^a   Ruebel, Katharina ^a   Kajita, Sabine ^a   Scheithauer, Bernd W ^a   Horvath, Eva ^b   Kovacs, Kalman ^b   Lloyd, Ricardo V ^a  

^a MAYO CLINIC   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

ACTH cell; Galectin 3; Pituitary tumor; RT PCR

Indexed keywords

ECALECTIN; GALECTIN; GALECTIN 1; GALECTIN 2; GALECTIN 3; GALECTIN 4; GALECTIN 5; GALECTIN 7; GALECTIN 8; PROLACTIN; UNCLASSIFIED DRUG;

ADENOMA; ARTICLE; BASOPHIL; CONTROLLED STUDY; CUSHING DISEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS; NELSON SYNDROME; NEUROHYPOPHYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADRENOCORTICOTROPIC HORMONE; ADULT; BLOTTING, WESTERN; FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 25844469041     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:16:2:107     Document Type: Article

References (39)

1. Riss D, Jin L, Qian X, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res 63(9):2251-2255, 2003.
2. Roncaroli F, Scheithauer BW, Cenacchi G, et al. "Spindle cell oncocytoma" of the adenohypophysis: a tumor of folliculostellate cells? Am J Surg Pathol 26(8):1048-1055, 2002.
3. Barondes SH, Cooper DN, Gilt MA, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269:20807-20810, 1994.
4. Amado M, Almeida R, Schwientek T, Clausen H. Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochem Biophys Acta 1473:35-53, 1999.
5. Furukawa K, Sato T. β-1,4-Galactosylation of N-glycans is a complex process. Biochem Biophys Acta 1473:54-66, 1999.
6. 2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res 59:6239-6245, 1999.
7. Ochieng J, Fridman R, Nangia-Makker P, et al. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 33:14109-14114, 1994.
8. Inohara H, Akahani S, Koths K, Raz A. Interactions between galectin-3 and Mac-2 binding protein mediate cell-cell adhesion. Cancer Res 56:4530-4534, 1996.
9. Nangia-Makker P, Honjo Y, Sarvis R, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156:899-909, 2000.
10. Yoshii T, Inohara H, Takenaka Y, et al. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Intl J Oncology 18:787-792, 2001.
11. Honjo Y, Nangia-Makker P, Inohara H, Raz A. Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 7:661-668, 2001.
12. Matarrese P, Fusco O, Tinari N, et al. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Intl J Cancer 85(40):545-554, 2000.
13. Gordower L, Decaestecker C, Kacem Y, et al. Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis. Neuropathol Appl Neurbiol 25:319-330, 1999.
14. Choi Kim H-R, Lin H-M, Biliran H, Raz A. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res 59:4148-4154, 1999.
15. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim H-R, Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 277:6852-6857, 2002.
16. Honjo Y, Inohara H, Akahani S, et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6(12):4635-4640, 2000.
17. Bresalier RS, Mazurek N, Sternberg LR, et al. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin-3. Gastroenterology 115(2):287-296, 1998.
18. Berberat PO, Friess H, Wang L, et al. Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J Histochem Cytochem 49(4):539-549, 2001.
19. Nakamura M, Inufusa H, Adachi T, et al. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 15(1):143-148, 1999.
20. Hsu DK, Dowling CA, Jeng KC, Chen JT, Yang RY, Liu FT. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 81(4):519-526, 1999.
21. Francois C, van Velthoven R, De Lathouwer O, et al. Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas. Am J Clin Pathol 112(2):194-203, 1999.
22. Xu X-C, El-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147:815-822, 1995.
23. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438(6):595-602, 2001.
24. Vidal S, Kovacs K, Bell D, Horvath E, Scheithauer BW, Lloyd RV. Cyclooxygenase-2 expression in human pituitary tumors. Cancer 97(11):2814-2821, 2003.
25. kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 151:509-519, 1997.
26. Jin L, Tsumanuma I, Ruebel KH, Bayliss JM, Lloyd RV. Analysis of homogeneous populations of anterior pituitary folliculostellate cells by laser capture microdissection and reverse transcription-polymerase chain reaction. Endocrinology 142:1703-1709, 2001.
27. Lahm H, Andre S, Hoeflich A, et al. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 127:375-386, 2001.
28. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W. Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Am J Pathol 98(3):617-638, 1980.
29. Kovacs K, Horvath E, Bayley TA, Hassaram ST, Ezrin C. Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. Am J Med 64(3):492-499, 1978.
30. Horvath E, Kovacs K. Ultrastructural diagnosis of human pituitary adenomas. Microsc Res Tech 20(2):107-135, 1992.
31. Horvath E. Ultrastructural markers in the pathologic diagnosis of pituitary adenomas. Ultrastruct Pathol 18(1-2):171-179, 1994.
32. Lloyd RV, Fields K, Jin L, Horvath E, Kovacs K. Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization. Am J Pathol 137(2):479-488, 1990.
33. Brathwaite SS, Clasen RA, D'Angelo CM. Silent corticotroph adenoma: case report and literature review. Endocr Prac 3:297-301, 1997.
34. Qian X, Jin L, Kulig E, Lloyd RV. DNA methylation regulates p27kip1 expression in rodent pituitary cell lines. Am J Pathol 153(5):1475-1482, 1998.
35. Lloyd RV, Jin L, Qian X, Kulig E. Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol 150(2):401-407, 1997.
36. Ruebel KH, Jin L, Zhang S, Scheithauer BW, Lloyd RV. Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas. Endocr Pathol 12(3):281-289, 2001.
37. Ruebel KH, Jin L, Qian X, et al. Effects of DNA methylation on galectin-3 expression in pituitary tumors. Cancer Res 65:1136-1140, 2005.
38. Yang R-Y, Liu F-T. Galectins in cell growth and apoptosis. Cell Mol Life Sci 60:267-276, 2003.
39. Poirier F. Roles of galectins in vivo. Biochem Soc Symp 69:94-103, 2002.